Journal of the Society for Gynecologic Investigation

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

http://mc.manuscriptcentral.com/rsci

SAGETRACK

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leipold, H.
Right arrow Articles by Krampl, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leipold, H.
Right arrow Articles by Worda, C.
Right arrow Articles by Özbal, A.
Right arrow Articles by Husslein, P.
Right arrow Articles by Krampl, E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of the Society for Gynecologic Investigation, Vol. 12, No. 7, 529-532 (2005)
DOI: 10.1016/j.jsgi.2005.05.003

First-Trimester Nuchal Translucency Screening in Pregnant Women Who Subsequently Developed Gestational Diabetes

Heinz Leipold, MD

Department of Obstetrics and Gynecology, University of Vienna Medical School, Vienna, Austria

Christof Worda, MD

Department of Obstetrics and Gynaecology, University of Vienna Medical School, Waehringer Guertel 18-20, A-1090 Vienna, Austria christof.worda{at}meduniwien.ac.at

Aral Özbal, MD

Peter Husslein, MD

Elisabeth Krampl, MD

Department of Obstetrics and Gynecology, University of Vienna Medical School, Vienna, Austria

Objective: To compare the nuchal translucency (NT) thickness at 11-14 weeks of gestation in women who will later develop gestational diabetes mellitus (GDM) with that of women with normal glucose tolerance (NGT) in the second trimester of pregnancy.

Methods: Four hundred sixty-four women underwent NT screening at 11-14 weeks of gestation according to the standards of the Fetal Medicine Foundation. They all underwent an oral glucose tolerance test (OGTT) between 24 and 28 weeks.

Results: Women with GDM (n = 135) were significantly older (34.0 years [±4.8] vs 29.4 years [±5.2]; P < .001), had a significantly higher body mass index (BMI) (28.2 kg/m2 [±6.0] vs 24.4 [±5.0]; P <.001), and had a significantly higehr serum concentration of hemoglobin A1c (HbA1c) at the time of the NT measurement (5.38% [± 0.6] vs 4.95% [±0.4]; P < .001] than women with NGT (n = 329). There is no significant difference in the NT measurement at 11 to 14 weeks of gestation between women with GDM and NGT after correction for crown rump length (CRL) (r = -.08, P = .45). We performed multiple linear regression analysis with NT as the dependent variable, and BMI, maternal age, CRL, and GDM/NGT as independent variables. CRL (P <.001) was significantly related to the NT measurement, whereas GDM/NGT, BMI, and maternal age were not.

Conclusion: As no significant difference in the NT measurement between women with GDM and NGT was observed, the risk estimation for chromosomal abnormality derived from the maternal age and NT measurement can also be used in women with glucose disorders.

Key Words: Gestational diabetes mellitus • nuchal translucency • pregnancy • ultrasound


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?